MARKET

NRXP

NRXP

Nrx Pharmaceuticals Inc
NASDAQ
4.000
+0.270
+7.24%
Pre Market: 3.880 -0.12 -3.00% 07:00 06/30 EDT
OPEN
3.810
PREV CLOSE
3.730
HIGH
4.040
LOW
3.715
VOLUME
5.05K
TURNOVER
0
52 WEEK HIGH
5.06
52 WEEK LOW
1.620
MARKET CAP
144.92M
P/E (TTM)
-3.1323
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at NRXP last week (0622-0626)?
Weekly Report · 1d ago
New to The Street Announces Broadcast of Show #759 on Bloomberg Television Across the U.S., MENA and Latin America tonight 630pm est.
Barchart · 2d ago
NRx Subsidiary HOPE Begins Patient Treatment Using AI-Guided TMS Systems
NASDAQ · 4d ago
NRx Pharmaceuticals Disputes Claims from Kadima
Dow Jones · 4d ago
NRx Pharmaceuticals issues response to Kadima statements
TipRanks · 4d ago
NRx Pharmaceuticals Issues Statement In Response To Kadima Allegations, Citing Arbitration Over Non‑Acquisition By HOPE Therapeutics
Benzinga · 4d ago
NRx Pharmaceuticals pushes Kadima dispute into arbitration amid acquisition lawsuit
PUBT · 4d ago
NRX PHARMACEUTICALS: CO DOES NOT BELIEVE THAT ACQUISITION/NON-ACQUISITION OF ANY INDIVIDUAL CLINIC WOULD BE MATERIAL TO HOPE'S OVERALL BUSINESS MODEL
Reuters · 4d ago
More
About NRXP
NRx Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company developing therapeutics based on its N-methyl-D-aspartate (NMDA) platform for the treatment of central nervous system disorders, specifically suicidal depression, chronic pain, and PTSD. It is developing NRX-100 (preservative-free intravenous ketamine) and NRX-101, (oral D-cycloserine/lurasidone). NRX-100 has been awarded Fast Track Designation for the treatment of Suicidal Ideation in Depression, including Bipolar Depression. NRX-101 has been awarded Breakthrough Therapy Designation for the treatment of suicidal bipolar depression. NRx has filed an Abbreviated New Drug Application (ANDA) and initiated a New Drug Application filing for NRX-100 (IV ketamine) with an application for the Commissioner’s National Priority Voucher Program for the treatment of suicidal depression. Its subsidiary, HOPE Therapeutics, Inc., is a healthcare delivery company that is building a network of interventional psychiatry clinics.

Webull offers NRX Pharmaceuticals Inc stock information, including NASDAQ: NRXP real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NRXP stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading NRXP stock methods without spending real money on the virtual paper trading platform.